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ABSTRAK: Virgin Cococnut Oil (VCO) dengan nama produk sesuai SNI Minyak 
kelapa Virgin, hubungannya dengan manfaat kesehatan, diproduksi dengan 
berbagai cara. Tujuan penelitian adalah untuk mempelajari metode proses 
pemngolahan VCO terhadap manfaat kesehatan dalam menurunkan kadar gula 
darah, profil kolesterol dan jaringan pankreas pada tikus Sprague dawley 
penderita Diabetes Melitus (DM).  Empat group dari lima group tikus diinjeksi 
alloxan  untuk membuat tikus tersebut sakit DM, sementara itu satu group 
dijadikan kontrol negatif (tikus sehat).  Tiga  group dari lima group tikus tersebut 
dicekok dengan masing-masing VCO-A yang diproduksi tanpa panas, VCO-B yang 
diproduksi dengan panas terkendali, serta minyak goreng kelapa atau Coconut 
Cooking Oil (RBD CNO) yang diproduksi menggunakan panas tinggi dan kimiawi, 
sementara 2 group lainnya dicekok dengan air sebagai  kontrol negatif (tikus 
sehat) dan kontrol positif  (tikus DM).  Dalam 28 hari pengamatan semua tikus 
diperiksa kadar gula darahnya, dan diakhir hari pengamatan semua tikus di 
bedah untuk mencek kolesterol dan profil jaringan pankreasnya.   VCO-A secara 
positif signifikan mengurangi kadar glukosa darah dinading yang lainnya.  VCO 
tidak mempengaruhi kadar kolesterol dan menghambat kerusakan sel β pancreas 
dari tikus DM. Dalam 28 hari pengamatan semua perlakuan VCO dapat 
mengurangi kadar glukosa darah tikus DM. 
 
Kata kunci: metode pengolahan VCO, diabetes mellitus, gula darah, jaringan pankreas 
 
ABSTRACT: Virgin Coconut Oil (VCO) can be produced by different methods  
related to health function. The objective was to study the efficacy of VCO 
processing method in reducing blood glucose level , cholesterol profile and 
pancreatic tissue profile of diabetic mellitus (DM) Sprague dawley rats. Four rat 
groups from five rat groups were injected using alloxan to induce the diabetic 
condition, while the rest was negative control. VCO-A produced without heat and 
VCO-B produced with controlled-heat treatment and Coconut Cooking Oil (RBD-
CNO) produced with the application of severe heating and chemical (MG) were 
fed respectively to three rat groups, while the other two rat groups were fed by 
water and used as negative control (healthy rats) and positive control (DM rats). 
During 28 days observation, all of the rats blood glucose level were assessed, and 
at the end of the observation day the rats were terminated to assess the 
cholesterol and pancreatic tissues profile. VCO-A significantly positive reduced 
blood glucose level than the others.  VCO did not influence DM rats cholesterol 
profile and all VCO inhibits the rate of pancreatic β cells damage. On 28 days 
observation all VCO treatments suppressed blood glucose level of DM rats. 
 
Keywords: processing method of virgin coconut oil, diabetes mellitus, blood glucose, pancreatic 
tissues  
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1. Introduction 
Virgin Coconut Oil (VCO) is one of value added 
products produced from coconut meat, which has 
higher economic value than coconut cooking oil. In 
the domestic and international market the price of 
VCO has a sale value of 10 to 20 times than the price 
of coconut cooking oil. This attractive price is due to 
the health benefits of VCO for human, such as for 
body health care, cosmetics and spa industries.  
Rindengan and Novarianto (2005), stated that 
there are various methods of manufacturing VCO i.e. 
the changing of the emulsion form of coconut milk, 
fermentation, enzymatic, centrifugations, direct 
heating, and the Intermediate Moisture Content 
(IMC) methods (Supriatna, et.al., 2000). 
Virgin Fats and Oils means edible vegetable fats 
and oils obtained by mechanical procedures and the 
application of heat only,  they may have been 
purified by washing with water settling, filtering and 
centrifuging (Codex, 2001). Based on these 
descriptions, VCO made by heat application without 
any chemicals for purification. 
The Lauric acid of VCO, as bioactive compound, 
will be metabolized into monolaurin in the body 
which is effective to kill germs of viruses, bacteria, 
fungi and protozoa (Enig, 1996).  The VCO reduce the 
levels of HIV / AIDS in the blood of patients  (Dayrit 
2005). VCO was also reported not to cause heart 
problems in Kerala study (Rethinam et al, 2005). 
Medium chain fatty acids in coconut oil are similar to 
the fatty acids of breast milk,  and VCO can be used 
to help in degenerative diseases treatment such as 
atherosclerosis, diabetes, cancer, obesity, stroke and 
others (Kabara, 2000). 
Among various degenerative diseases, diabetes  
may cause complications,  such as renal disease, 
cardiac disorders, gastrointestinal disorders, blood 
vessel blockage, decay and leg amputations, 
blindness, erectile dysfunction, disturbances of 
touch sensitivity (numbness), pain throughout the 
body, and death (Wibowo, 2005). 
VCO  may  prevent complications of diabetes 
mellitus by inducing  insulin secretion in the 
diabetics as VCO is easily absorbed. Inside the body, 
the lauric acid and capric acid of VCO, , stimulates the 
secretion of insulin by Langerhans cells of the 
pancreas (Garfinkel et al, 1992). 
According to the International Diabetes 
Federation (IDF) there are approximately 177 
million people worldwide suffered from diabetes, 
and mostly type-2 diabetes (Anon, 2006), and WHO 
predicts it may increase up to 300 million people in 
the next 25 years. 
This research was conducted to find out the 
health benefits of VCO, especially for diabetes 
mellitus, and to find out scientific evidence on 
efficacy of VCO produced with and no-heat well as 
low heat treatments, especially on the the efficacy 
medium chain saturated fatty acids (C6-C12) in VCO 
in lowering blood glucose levels of diabetes mellitus 
in rodent model. 
Based on the above description, research 
problems are formulated as follows: Does the 
processing method of VCO affect the activity 
bioactive compound of medium chain saturated 
fatty acid on decreasing blood glucose levels, 
affecting the cholesterol value and pancreatic tissue 
profile of diabetes mellitus rats. 
2. Materials and Methods 
2.1. Materials 
The materials consisted of VCO, coconut cooking 
oil, male Sprague Dawley rats, rats feed, and 
chemicals. Two types of VCO, VCO-A is the VCO 
which is processed without heat (VA) and bought 
from VCO supplier in Bogor, and VCO-B is the VCO 
which is processed using the controlled heat (VB) 
and made in CABI. Meanwhile, the commercially 
branded coconut cooking oil (MG) represents the 
coconut oil processed using high heat and chemical 
purification and purchased from a supermarket in 
Bogor. 
Sprague Dawley male rats with body weight 
ranging from 150 to 250 grams, were purchased 
from “Langit Biru” a breeder rats at Taman Kencana  
Bogor.  The materials for the rat feed formulation 
were purchased from a supermarket in Bogor, and 
the Chemistry Stores in Bogor. Alloxan for inducing 
rats into diabetes mellitus was ordered from 
Singapore. The chemical substances for chemical 
analysis such as monochloride iodine, acetic acid, 
siclo-hexan, 20% potassium iodide, sodium 
thiosulfate 0.1 N, Wijs solution, 95% neutral alcohol, 
NaOH, KOH, phenolftalein 0.5%, chloroform, HgO 
crystals, helium, hydrogen, BF-3 Methanol, 
petroleum ether p.a. were obtained from CABI. 
Chemical substances for treatment of rats pancreatic 
organs such as Bouin solution, a solution of 
dehydration (alcohol 70%, alcohol 80%, alcohol 
90%, alcohol 95% and absolute alcohol), xylol, 
haematoxylin, eosin, antibody monoclonal insulin 
(Sigma I2018), PBS, diaminobenzidine, normal 
serum, H2O2, methanol, distilled water (DW), 
conjugated antibodies, paraffin, adhesive, 
neofrendan etc. were obtained from the Histological 
Laboratory Veterinary Faculty of Bogor Agricultural 
University. 
2.2. Methods 
Based on field observations, the VCO-A was 
made by centrifuge technology without any heat 
application. 
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VCO-B (VB) was produced by CABI using the 
Intermediate Moisture Content (IMC) technology 
without going through coconut milk step. In IMC 
technology VCO obtained from fresh grated coconut 
meat which is dried directly using artificial drying 
method with controlled temperature at 60oC prior to 
pressing. 
The coconut cooking oil used in the study was 
commercially branded coconut cooking oil in the 
market. Based on field observations, the coconut 
cooking oil production is carried out through the 
process by pressing copra and then the oil obtained 
is purified in a special purification plants using high 
heat and chemicals.  
2.2.1. Animal experiment 
Before starting the research, all Sprague Dawley 
rats were subjected to an adaptation period for 6 
days,  and were observed for their health condition 
and  fed with basic feed and water on ad libitum. 
After going through a period of adaptation, the 
rats were fasted for 1 night, and then injected 
intravenously with alloxan (110 mg / kg of rat body 
weight) . After 2 days, their serum glucose level was 
measured by using glucometer. The rats  with serum 
glucose levels more than 200 mg/dl categorized  as  
suffered from diabetic mellitus, and then classified 
to 4 groups (n = 5). The groups consisted of positive 
control (K+), VA , VB  and MG , in addition, one group 
of  healthy rats  (n = 5) was not injected with alloxan, 
as a negative control group (K-).  
All 5 groups of rat were fed with basic feed and 
drinking water every day ad libitum. In addition, 
VCO and coconut cooking oil were administered 
orally to each group of the rats every day, 
respectively for 28 days. The dose of VCO or coconut 
cooking oil was 0.81 ml per day per 200g of rat 
weight.  This dosage was obtained from a conversion 
factor of 0.018 on the basis of human weight of 70 kg 
(Harmita and Maksum, 2005) supplemented with 1 
table spoon VCO or MG 3 times a day, equivalent to 
45 ml per day. Both the positive and negative control 
groups were not administered orally neither with 
VCO nor coconut cooking oil and were administered 
orally with 1 ml drinking water (irrespective of the 
rat weight). 
2.3. Observation and analysis 
During the research, every 4 days theirs blood 
glucose levels of the rats in each group were 
observed from each tail   using a Glucometer 
instrument (Henry, 2002). The blood withdrawn 
from each rats tail using syringe of Glucometer.  The 
drop of blood from the tail swab to the test strips 
apparatus of glucometer (Allmedicus, USA).  At the 
end of the research on the 29th observation day all 
the rats were sacrificed, and their cholesterol, LDL 
and HDL level of the blood obtained from their heart 
organ were analyzed.  In addition, at the end of 
treatment, the following activities were performed : 
the sampling of pancreas organ, fixation, 
dehydration, clearing, paraffin infiltration, 
embedding, sectioning, staining, mounting, and 
making photomicrograph.   
2.4. Research place 
The research was conducted at Laboratory of 
Animal Experiment, Department of Food Science 
and Technology, Faculty of Agricultural Technology 
and SEAFAST Center (South East Asia Food and 
Agriculture Science and Technology) Bogor 
Agricultural University, Laboratory of Histology 
Faculty of Veterinary Medicine, Bogor Agricultural 
University, and at the Center for Agro-Based 
Industries (CABI) Ministry of Industry, Bogor 
Indonesia. 
2.5. Statistical analysis 
Experimental Design of the research was 
Completed Randomize Design. If the treatment  
effect was significant, continuous test was then 
conducted using LSD (Least Significant Difference) 
or Duncan at p value 5% or 1% significant level.   
Statistical analysis was done using software SPSS 13. 
3. Result and Discussion 
3.1 Serum blood glucose level 
After alloxan treatment, except for the negative 
group of rats (the healthy rat group), the rest of the 
rat groups condition of baseline had serum blood 
glucose level more than 200 mg/dl categorized as 
suffered from diabetic mellitus. All 5 groups of rat 
were fed with basic feed and drinking water every 
day ad libitum. In addition, VCO and coconut cooking 
oil were administered orally to each group of the rats 
every day. 
Figure 1 shows that the average value of serum 
blood glucose levels for the K+ (Positive Control) rat 
groups and MG rat groups (the rats fed by coconut 
cooking oil) tend to be higher than  the other rat 
groups, since the positive control group were  
conditioned to suffer from diabetes and no 
treatment for diabetic. Although statistically no 
significant different, the blood glucose levels MG rat 
groups (rats treated with the coconut cooking oil) 
decreased, with the decreasing value was smaller 
than that of other groups treated with VCO (VA and 
VB rat groups), may be caused by the manufacturing 
process of coconut cooking oil which uses high 
temperature and chemicals. 
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Figure 1. The Average of Serum Blood Glucose Level  of Rats 
 
There were no significant difference of serum 
blood glucose level among all group of treatments, 
but Spearman's rho correlation analysis shows that 
compared to other rat groups, VA rat group has the 
most closely correlated in lowering blood glucose of  
diabetic rats. The data show that the correlation 
value of VA rats group is -0.929 which means that 
during the observation time, glucose levels 
decreased very closely and significantly different at 
1% level. Meanwhile VB rat group had a correlation 
value of -0.762 and significantly different at 5% 
level. The result shows that the application of heat in 
the production process of VCO has a significant 
different effect on the activities of bioactive 
compound fatty acids in lowering blood glucose 
levels of diabetic rats.  
Fife (2001) stated that the Medium Chain Fatty 
Acids (MCFA) in coconut oil has small enough 
molecular weight to enter the cell without the help 
of the insulin hormone. In other words MCFA can 
enter the cells regardless the existence of insulin or 
even if the cell is insulin resistant. Further, Garfinkel 
et al. (1992) and Han et al (2003) explained that 
coconut oil can help regulate blood sugar, because 
the bioactive compound contained is the MCFA 
which can increase insulin production and 
sensitivity. In line with the above findings, Opara et 
al (1994) stated that Lauric acid as a MCFA is fatty 
acids that increase the highest percentage basal 
insulin output compared to the short or long chain 
fatty acids. 
3.2 Blood serum cholesterol 
Figure 2 shows that total cholesterol value of all 
rats was below of the danger threshold.  The safe 
threshold for total cholesterol is <200 mg/dl (Henry, 
2002 and American Diabetes Asociation, 2004).  This  
 
 
 
Figure 2. Serum Cholesterol Level in  Each Group of Rats. 
 
is in accordance with the statement of Rethinam and 
Bosco (2006), that medium chain saturated fatty 
acid did not increase blood cholesterol. 
Figure 2 indicates that VCO treatments (VA and 
VB rat groups) relatively did not alter the levels of 
total cholesterol, HDL, LDL and triglycerides of 
diabetic mellitus rat blood serum compared to those 
of the K+ rat group. The European Task Force on 
Coronary Prevention recommends for decreasing 
the total cholesterol <190 mg / dl and LDL i.e. <115 
mg / dl (Henry, 2002). Research data as showed in 
Figure 2, that the total cholesterol of K+ rat group is 
76.4 while the VA and VB rats groups were 68.0 and 
76.0, respectively, means that 28 days consumption 
did not increase levels of total cholesterol of diabetic 
rats. 
According to Henry (2002) low concentrations of 
HDL <39 mg / dl for men and <43 for women, 
especially when associated with fasting triglyceride 
values > 180 mg / dl, estimated to be at high risk for 
coronary heart disease. Based on Figure 2, the levels 
of HDL cholesterol and triglycerides of the VCO 
treated rat groups (VA and VB rat groups) are on 
safe threshold. This result in line with the study of 
Rethinam and Bosco (2006) that stated fatty acids of 
the VCO are rapidly absorbed by the rat’s body  do 
not deteriorate the rat’s body lipid.  
Figure 2 shows that VCO consumption in VA and 
VB   compared to control positive group. However, 
the increased LDL value was still below the 
threshold. The European Task Force on Coronary 
Prevention recommends for lowering total 
cholesterol i.e. <190 mg / dl and LDL i.e. <115 mg / 
dl. Meanwhile, according to the American Diabetes 
Association (2004) normal LDL value was <160 mg 
/ dl (Henry, 2002). 
Likewise, Figure 2 shows that the K+ rat group or 
untreated diabetic rats, has higher triglyceride value 
than VA, VB and MG groups. This shows that the 
triglyceride value of K+ rats group i.e. 153.6 can be 
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reduced by the VCO treatment. The triglyceride 
value of the treated VA and VB rat groups are 86 and 
75.6 respectively. In other words VCO did not 
increase the value of blood triglycerides of diabetic 
rats. As previously mentioned, this happens because 
of VCO can be quickly absorbed by the body, 
converted into energy, and is not stored as body fat,  
therefore the VCO did not affect the condition of the 
body lipids (Rethinam and Bosco, 2006). 
Based on the results of this research, it was found 
that during the 28 days-observation the VCO orally 
fed to the diabetic rats did not significantly increased 
triglyceride values. Similar study conducted by 
Rajamohan (1997), shows that coconut oil 
consumption provides the total cholesterol and 
triglycerides lower than that of peanut oil. 
3.3 Profile of pancreatic organ 
Haematoxylin-Eosin (HE) tinting was conducted 
to see in a qualitative way the general morphology of 
pancreatic tissue of rats. This tinting composed of 
two color components, haematoxylin and Eosin. 
Haematoxylin is an alkaline dye ,colored the acidic 
cell nucleus whereas Eosin is an acidic dye colored 
the alkaline cytoplasm (Banks 1993). The observed 
parameters of HE tinting   in the preparations of the 
pancreas is a general morphology of pancreatic 
tissue and the number of Langerhans island. The 
pancreatic organ tissues of K+ and MG rat groups 
showed the number of degenerating and necrotizing 
of acinar cells, higher than VA and VB rat groups. The 
pancreatic organ tissue of VA and VB rat groups have 
only a very few number of degenerating and 
necrotizing acinar cells as shown in Figure 3. 
 
 
 
Figure 3. The Acinar Cells of Pancreatic Organ of Each Rat Group 
 
The counting results of the pancreatic tissue’s 
Langerhans islands of rat groups per five fields of 
view are presented in Table 1. 
 
 
 
 
 
 
 
 
Table 1.  
The average number of langerhans islands of pancreatic tissues of 
each rat group with x 20 magnification 
Rats Group The Number of Langerhans Island (unit)  
K(-) 3.40 ± 1.18b 
K(+) 1.40 ± 1.06a 
VA 2.13 ± 1.46a 
VB 1.93 ± 2.12a 
MG 1.53  ± 1.18a 
Remark: The Different Superscript on the Same Column Indicated 
The Significant Different (p<0.05) 
 
 
Based on statistical analysis of Variant 
(ANNOVA), the number of Langerhans islands of the 
K- rat group was significantly higher (p <0.05) 
compared to other rat groups, since this group is 
healthy rats. While the K+, VA, VB, and MG groups 
have no significant difference in Langerhans islands 
number among the groups, as shown by  stable 
number of Langerhans islands during 28 days. Yet 
the number of Langerhans islands cannot describe 
the damage of pancreatic tissues and cells in them. 
These tissues and cells cannot be detected by 
haematoxylin-Eosin tinting (HE). Therefore, it needs 
advanced tinting  by using immuno histochemical to 
detect the ß cells within the Langerhans islands. The 
results of β cell counting of the pancreatic tissues of 
rats within the Langerhans islands per three fields of 
view are presented in Table 2. 
 
Table 2.  
The average number of β cells of pancreatic tissues in langerhans 
islands with x 20 magnification 
Rat Groups The Number of β Cells in Langerhans Islands 
(Unit) 
K(-) 63.44 ± 15.29c 
K(+) 10.11 ± 6.95a 
VA 22.78 ± 7.03b 
VB 18.89 ± 8.27b 
MG 8.67 ± 3.12a 
Remark:  The Different Superscript on the Same Column Indicates 
the Significant Difference (p<0.05 
 
Observations of the β cells were quantified by 
counting the number of β cells in each rat pancreas. 
β cells detected by immune histochemical staining 
were indicated by the dark brown color in the 
Langerhans island cells, while others were blue. The 
blue color comes from the counter staining by using 
haematoxylin dye which colors the pancreas cells.  
The results of statistical analysis show that the 
number of β cells of Pancreatic tissues of VA and VB 
groups is significantly higher (p <0.05) than those of 
group K (+) and group MG rats although it is 
significantly lower (p <0.05) than that of the group K 
(-) rats.  
Diabetes mellitus causes a situation in which the 
body cannot control blood glucose levels due to the 
disruption of insulin secretion by β cells in the 
pancreatic tissues of Langerhans islands. The 
process of glucose metabolism is very important to 
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generate energy for the survival of cells in the body. 
However, diabetes mellitus makes the body cells 
unable to metabolize glucose so the body suffers 
from energy shortage. Consequently, the body looks 
for alternative energy through Glycogenolysis and 
gluconeogenesis. Both processes produce by-
products of free radicals that can cause damage to 
the body's cells including pancreatic cells. Alloxan is 
one of the substances for inducing experimental 
diabetes mellitus which selectively destroys 
pancreatic β cells (Walde et al. 2002). Diabetes 
mellitus suffered by rats in this study was due to the 
damaged pancreatic β cells induced by Alloxan 
which results in the decreased insulin secretion. 
According to Szkudelski (2001), Alloxan damages 
pancreatic β cell through the formation of reactive 
oxygen species preceded by the reduction of Alloxan. 
Alloxan reacts with reducing agents such as cysteine 
and enzymes belonging to an SH-group. SH-
glucokinase is an enzyme that plays an important 
role in insulin secretion, therefore, Alloxan has a 
high affinity for the glucokinase enzyme. Alloxan 
reacts with two SH-groups of the glucokinase 
enzyme to form a dimeric bond which inactivates the 
enzyme and disturbs the insulin secretion. 
Eventually it damages β cells and results in the state 
of diabetes. 
Alloxan is also the free radicals that can damage 
biomacromolecules such as lipids, phospholipids, 
and carbohydrates that are the components of cell 
walls (Lenzen 2007), and the DNA inside the 
nucleus. The DNA in the nucleus was also attacked 
by free radicals. If DNA damage is not too much, it 
can be improved. However, the recovery process 
often causes cell mutation which can eventually 
become cancer (Aruoma 1998). General morphology 
of pancreatic tissue and cell damage inside acinar 
cells and the number of Langerhans islands can be 
seen by haematoxylin-Eosin tinting (HE). The 
pancreatic tissues of group K (-) has the least 
amount of acinar cell degeneration and nekrosa but 
has the highest number of Langerhans islands 
compared with other treatment groups. This is 
because pancreatic tissues of treatment group K (-) 
are not induced by Alloxan, thus diabetic condition 
does not appear.  Meanwhile the pancreatic tissues 
of the treatment group K (+) has a higher number of 
degenerated acinar cells to nekrosa compared with 
the treatment groups of VA and VB.  It is because the 
pancreatic tissues of treatment group K (+) are 
induced by Alloxan and merely fed with water so the 
acinar cells deteriorate quickly.  
Pancreatic tissues of group VA and VB have fewer 
acinar cells degenerating to nekrosa compared with 
the K (+) and MG, because the pancreas of group VA 
and VB induced by Alloxan receive VCO intake from 
the body, so the rate of damaged cells can be 
inhibited. VCO contains Lauric Acids, a medium 
chain saturated fatty acids, which have been 
reported to increase insulin secretion (Garfinkel et 
al 1992). Increased secretion of insulin causes the 
search for glucose alternatives to be reduced which 
results in fewer by products of free radicals. The rate 
of cell damages in pancreatic tissue group VA and VB 
can be inhibited so that the amount of cell damage 
becomes fewer than the group K (+) and MG. With 
HE tinting, the number of Langerhans islands is not 
significantly different among group K (+), VA, VB, 
and MG. To be able to detect β cells contained in the 
Langerhans islands, the advanced colouring is done 
with immunohistochemical techniques. β Cell 
detection in immunohistochemical may indicate a β 
cell damage in diabetes mellitus condition. 
Pancreatic tissues of group K (+) has the least 
amount of β Cell compared with other groups, this is 
because the pancreatic tissues of K (+) were induced 
by Alloxan and treated with drinking water only 
resulting in the high rates of β cellular damages 
while the insulin secretion becomes very low. 
Reduction of insulin secretion that occurs in  β  cells 
of group K (+) was caused by Alloxan which 
inactivated the glucokinase enzyme. Glucokinase is 
an enzyme-with SH group which has an important 
role in the secretion of insulin in the pancreas. 
Alloxan has a high affinity with proteins having-SH 
groups, therefore, Alloxan reacts with the two SH-
groups of glucokinase which results in the dimer 
bond causing the inactivation of enzymes and being 
responsible for the β cell decay (Szkudelski 2001). In 
addition, Alloxan also reduces ATP production, 
causing the opening of K + channels and the plasma 
membrane hyperpolarization. Then, it was followed 
by the closing of the gate voltage that causes Ca2 + 
Ca2 + concentration decrease resulting in decreased 
secretion of insulin and cell decay (Drews et al. 
2000). 
In the MG treatment group, the number of β cells 
produced was not much different from that of the K 
(+). In a diabetic condition, the search for glucose 
alternatives produces by products of free radicals. 
The high amount of free radicals due to the diabetic 
condition will increase further with the 
consumption of cooking oil containing a few 
unsaturated fatty acids that will increase lipid 
oxidation, which will also produce by products of 
free radicals.  As a result, the free radicals present in 
the pancreas of MG treatment group will be even 
higher. This will eventually make the function of β 
cells of the pancreas decrease causing the reduced 
insulin secretion which will make the faster rate of β 
cells decay in pancreatic tissues of MG treatment 
group faster. Consequently, the number of β cells 
becomes fewer. Pancreatic tissues of treatment 
group VA and VB have higher amount of β cells than 
that of the treatment group K (+) and MG.  It 
indicates that there is an inhibition of the rate of 
Warta IHP/Journal of Agro-based Industry Vol.35 (No.2) 12 2018: 91-98 
Halaman | 97 
© WIHP; P-ISSN 0215-1243; E-ISSN 2654-4075; 2018; All rights reserved 
damage to the Langerhans island of β cells in the 
treatment group VA and VB. The secretion of insulin 
in the group VA and VB is triggered by the increased 
concentration of intracellular Ca2 + released by the 
gate voltage of Ca2 + channels within the β cell 
plasma membrane. The medium chain saturated 
fatty acids play an important role in the activation of 
the Ca2 + channel resulting in mobilization of 
intracellular Ca2 + that triggers the release of insulin 
from β cells (Gravena et al. 2002). The saturated 
fatty acids that play an important role in stimulating 
insulin secretion is Lauric acid, palmitic acid, and 
capric acid contained in the VCO (Garfinkel et al. 
1992). Increased secretion of insulin causes the 
search for glucose alternatives to be reduced, and 
the by product of free radicals produced is less. Thus 
β cells damage can be inhibited and the number of β 
cells present in the pancreas of treatment group VA 
and VB is higher than that of K (+) and MG. However, 
the number of β cells in the pancreas of the 
treatment group VA and VB is still less than that of 
the treatment group K (-). It is because pancreatic 
tissues of treatment group K (-) are not induced by 
Alloxan.   
As diabetic condition did not arise in this group, 
the number of β cells remains intact. In addition to 
medium chain saturated fatty acids, VCO also 
contains vitamin E and antioxidants. Antioxidants 
contained in VCO can neutralize free radicals that 
accumulate in cells due to diabetes mellitus so β cell 
damage caused by free radicals can be inhibited. 
4. Conclusion 
Non heated and controlled heated VCO showed 
no significant effect on lowering blood glucose level, 
but on lowering blood glucose, VCO A (without heat) 
has closer correlation and very significant difference 
(-0.929 correlation value at p <1%), compared to 
VCO B (controlled heat) (correlation value of -0.762, 
at  p <5%)  and coconut cooking oil ( -0.524 
correlation value at  p> 5%) 
 Non heated VCO (VA) showed significant 
positive correlation with blood glucose level (-0.929 
correlation value at p <1%), while controlled heated 
VCO (VB) significantly different at p 5% level but  
coconut cooking oil could not lowering the blood 
glucose level.  
VCO and coconut cooking oil showed no 
significant effects on raising the level of total 
cholesterol, HDL value, LDL value and serum 
triglyceride of diabetic mellitus rats at p 5% level.  
The virgin coconut oil significantly inhabited cell 
damage of pancreatic tissue on the Langerhans 
island of diabetic mellitus rats. 
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